MX2019011775A - Metodos para la cuantificacion de insulina y peptido c. - Google Patents

Metodos para la cuantificacion de insulina y peptido c.

Info

Publication number
MX2019011775A
MX2019011775A MX2019011775A MX2019011775A MX2019011775A MX 2019011775 A MX2019011775 A MX 2019011775A MX 2019011775 A MX2019011775 A MX 2019011775A MX 2019011775 A MX2019011775 A MX 2019011775A MX 2019011775 A MX2019011775 A MX 2019011775A
Authority
MX
Mexico
Prior art keywords
insulin
methods
peptide
mass spectrometric
quantitation
Prior art date
Application number
MX2019011775A
Other languages
English (en)
Inventor
J Mcphaul Michael
Shiffman Dov
Tong Carmen
j devlin James
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2019011775A publication Critical patent/MX2019011775A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724—Nebulising, aerosol formation or ionisation
    • G01N30/7266—Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ecology (AREA)
  • Dispersion Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se describen procedimientos para el diagnóstico o pronóstico de la resistencia a insulina en pacientes diabéticos y prediabéticos, el método que comprende la determinación de la cantidad de insulina y péptido C en una muestra. En este documento se proporcionan métodos de espectrometría de masas para detectar y cuantificar insulina y péptido C en una muestra biológica que utiliza métodos de enriquecimiento y/o purificación junto con técnicas de espectrometría de masas en tándem o de alta resolución/alta precisión.
MX2019011775A 2017-03-31 2018-03-30 Metodos para la cuantificacion de insulina y peptido c. MX2019011775A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762480029P 2017-03-31 2017-03-31
US201862644378P 2018-03-16 2018-03-16
PCT/US2018/025575 WO2018183966A2 (en) 2017-03-31 2018-03-30 Methods for quantitation of insulin and c-peptide

Publications (1)

Publication Number Publication Date
MX2019011775A true MX2019011775A (es) 2020-02-05

Family

ID=63676885

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011775A MX2019011775A (es) 2017-03-31 2018-03-30 Metodos para la cuantificacion de insulina y peptido c.

Country Status (8)

Country Link
US (2) US10983108B2 (es)
EP (2) EP4220157A1 (es)
JP (2) JP7337701B2 (es)
CN (1) CN110914691A (es)
BR (1) BR112019020473A2 (es)
CA (1) CA3058642A1 (es)
MX (1) MX2019011775A (es)
WO (1) WO2018183966A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
EP2939024B1 (en) 2012-12-26 2021-04-28 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
CA2935960C (en) 2014-01-08 2023-01-10 Bart Lipkens Acoustophoresis device with dual acoustophoretic chamber
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
BR112020009889A2 (pt) 2017-12-14 2020-11-03 Flodesign Sonics, Inc. acionador e controlador de transdutor acústico
CN115951072B (zh) * 2022-12-06 2024-05-14 北京鸿宇泰生物科技有限公司 一种糖化血红蛋白-c肽联合检测试剂盒

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
CA2163426C (en) 1993-05-28 2005-11-01 T. William Hutchens Method and apparatus for desorption and ionization of analytes
US5772874A (en) 1995-11-02 1998-06-30 Cohesive Technologies, Inc. High performance liquid chromatography method and apparatus
PL327920A1 (en) 1996-01-19 1999-01-04 Cohesive Technologies Highly efficient liquid chromatography process and chromatographic apparatus therefor
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
JP2002502086A (ja) 1998-01-23 2002-01-22 アナリティカ オブ ブランフォード インコーポレーテッド 表面からの質量分光測定
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
GB2404784B (en) 2001-03-23 2005-06-22 Thermo Finnigan Llc Mass spectrometry method and apparatus
AU2003218649B2 (en) 2002-02-28 2007-09-06 Metanomics Gmbh & Co. Kgaa Mass spectrometry method for analysing mixtures of substances
JP2008534987A (ja) 2005-04-05 2008-08-28 プロテイン・デイスカバリー・インコーポレーテツド マトリックス支援レーザー脱離イオン化（ｍａｌｄｉ）質量分析法（ｍｓ）を含む化学分析のための検体の濃縮と分別のために改良された方法と装置
WO2006124713A2 (en) 2005-05-13 2006-11-23 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-ones
DE602007008565D1 (de) 2006-06-27 2010-09-30 Biolipox Ab Verfahren zur identifizierung von modulatoren der eoxin-bildung
ZA200902588B (en) 2006-11-09 2010-06-30 Alcon Res Ltd Punctual plug comprising a water-insoluble polymeric matrix
WO2008150488A1 (en) 2007-06-01 2008-12-11 Laboratory Corporation Of America Holdings Methods and systems for quantification of peptides and other analytes
WO2009018307A2 (en) 2007-07-31 2009-02-05 Wyeth Analysis of polypeptide production
CN101896461A (zh) 2007-12-13 2010-11-24 安姆根有限公司 γ分泌酶调节剂
EP2283349A1 (en) 2008-04-29 2011-02-16 Becton, Dickinson & Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
ES2433691T3 (es) 2008-07-17 2013-12-12 Ikfe Institut Für Klinische Forschung Und Entwicklung Gmbh Biomarcadores para la insulinorresistencia y disfunción de células beta
CN105067698B (zh) * 2009-11-05 2018-11-20 奎斯特诊断投资公司 用高分辨率质谱法量化胰岛素样生长因子-i和胰岛素样生长因子-ii
JP6271250B2 (ja) * 2010-09-21 2018-01-31 プロテオミクス インターナショナル プロプライエタリー リミテッドＰｒｏｔｅｏｍｉｃｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｔｙ Ｌｔｄ 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー
WO2012092281A2 (en) 2010-12-28 2012-07-05 Quest Diagnostics Investments Incorporated Quantitation of insulin by mass spectrometry
US8669519B2 (en) 2011-12-05 2014-03-11 Quest Diagnostics Investments, Inc. Methods for detecting reverse triiodothyronine by mass spectrometry
CN103454433B (zh) 2012-06-05 2016-08-03 许洋 一种新型检测内外源性胰岛素的免疫质谱试剂盒
US20130344048A1 (en) * 2012-06-21 2013-12-26 David H. Wasserman Method of reducing insulin resistance by administering a Hyaluronan-degrading enzyme
EP2939024B1 (en) 2012-12-26 2021-04-28 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
EP3321686B1 (en) 2013-01-31 2024-03-13 Metabolon, Inc. Biomarkers related to insulin resistance progression and methods using the same
WO2016127144A1 (en) * 2015-02-06 2016-08-11 University Of North Texas Health Science Center At Fort Worth Methods and tools for diagnosing insulin resistance and assessing health status usng nmr relaxation times for water
US10324082B2 (en) * 2015-03-03 2019-06-18 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry
US20160357935A1 (en) * 2015-06-04 2016-12-08 True Health Diagnostics Llc Novel set of fasting blood biomarkers to detect patients with impaired glucose tolerance

Also Published As

Publication number Publication date
WO2018183966A3 (en) 2019-01-17
US20190079070A1 (en) 2019-03-14
EP3602071A4 (en) 2020-11-04
EP3602071B1 (en) 2022-12-07
CN110914691A (zh) 2020-03-24
US10983108B2 (en) 2021-04-20
EP4220157A1 (en) 2023-08-02
CA3058642A1 (en) 2018-10-04
JP2020515856A (ja) 2020-05-28
WO2018183966A9 (en) 2020-01-23
EP3602071A2 (en) 2020-02-05
JP2023169161A (ja) 2023-11-29
US20220042971A1 (en) 2022-02-10
WO2018183966A2 (en) 2018-10-04
JP7337701B2 (ja) 2023-09-04
BR112019020473A2 (pt) 2020-04-28

Similar Documents

Publication Publication Date Title
MX2019011775A (es) Metodos para la cuantificacion de insulina y peptido c.
MX2017011312A (es) Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
BR112014016313A2 (pt) medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
SG154410A1 (en) System and method for measuring an analyte in a sample
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
WO2012097081A3 (en) Protein detection method
MX2018013686A (es) Abundancia fraccional de secuencias de polinucleotidos en una muestra.
EP4220170A3 (en) Method for detecting a solid tumor cancer
EP4234710A3 (en) Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
WO2013026026A3 (en) Shift correction for spectral analysis
BR122019018448B8 (pt) método para extração de succinilacetona e um ou mais analitos biológicos adicionais
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN
EP3460478A4 (en) METHOD AND SYSTEM FOR BLOOD SAMPLING FOR DETERMINING DIABETES
MX2019002918A (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto.
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
BR112022009371A2 (pt) Métodos para determinar a quantidade ou concentração de um ou mais analitos antibióticos, tubos de amostragem, usos de um reagente de derivatização nucleofílica e analito antibiótico
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
ES2845150T3 (es) Diagnóstico de pancreatitis aguda (PA) mediante la detección de glicoproteína 2 isoforma alfa (GP2A)
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
WO2016118920A3 (en) Metabolomic based biomarkers for colon cancer detection